SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
Commission File Number 0-13012
NOTIFICATION OF LATE FILING
(Check One): (X) Form 10-Q
For Period Ended: September 30, 2000
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
PART I
REGISTRANT INFORMATION
Full name of registrant ESC MEDICAL SYSTEMS LTD.
Former name if applicable N/A
Address of principal executive office (Street and number) P.O. BOX 240
City, State and Zip Code YOKNEAM, ISRAEL, 20692
PART II
RULE 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)
{ (a) The reasons described in reasonable detail in Part III of this
{ form could not be eliminated without unreasonable effort or
{ expense;
{ (b) The subject annual report, semi-annual report, transition report
{ on Form 10-K, 20-F, 11-K, or Form N-SAR, or portion thereof will
{ be filed on or before the 15th calendar day following the
(X) { prescribed due date; or the subject quarterly report or
{ transition report on Form 10-Q, or portion thereof will be filed
{ on or before the fifth calendar day following the prescribed due
{ date; and
{ (c) The accountant's statement or other exhibit required by Rule
{ 12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K,
20-F, 10-Q, N-SAR or the transition report portion thereof could not be
filed within the prescribed time period. (Attach extra sheets if needed)
ESC Medical Systems Ltd. (the "Company") required additional time to
gather its financial and other information in order to file its 10-Q for
the period ending September 30, 2000. The Company has since gathered all
the required information and will file its quarterly report on Form 10-Q
as soon as practically possible.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Sharon Levita 972 4-959-9000
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s)
(X) Yes ( ) No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report
or portion thereof?
(X) Yes ( ) No
The Company's net income was $11,576 for the nine months ended
September 30, 2000 compared to a net loss of $121,597 in the period in
1999. The improvement in net income is due to the adoption of a
restructuring plan, mainly designed to align the Company's cost structure
with its revenue capabilities, an increase in sales and improvement in
gross margins and the sale of Applied Optronics Corp.
ESC MEDICAL SYSTEMS LTD.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: November 15, 2000 By: /s/ Sagi A. Genger
---------------------------------
Name: Sagi A. Genger
Title: Chief Financial Officer
